New Delhi: Johnson & Johnson’s COVID-19 vaccine candidate’s late-stage study was paused as the company probes into a participant’s “unexplained illness”.
In a statement on Monday, the company said that illnesses, accidents and other so-called adverse events “are an expected part of any clinical study, especially large studies,” but that its physicians and a safety monitoring panel would try to determine what might have caused the illness.
The halt in the trial is at least the second such pause to occur among several vaccine candidates that have reached large-scale final tests in the United States.
The company refused to divulge any more details about the illness, citing the participant’s privacy.
Port Louis/New Delhi: Prime Minister Narendra Modi landed at Port Louis, the capital city of… Read More
Berhampur: At least seven persons were critically injured in a violent clash between residents of… Read More
Mumbai: Following a sharp decline in US markets overnight, the Sensex fell nearly 400 points,… Read More
Rayagada: A cook and an attendant of a government-run hostel in Odisha’s Rayagada district were… Read More
Stay ahead with Odisha Bytes Breaking News - your ultimate source for the fastest, most… Read More
Mumbai: Popular television actress Hina Khan, a stage 3 breast cancer survivor, got emotional recently… Read More
This website uses cookies.